ClinicalTrials.govpublic full text
Dapagliflozin in Respiratory Failure in Patients With COVID-19
covid-19, sodium-glucose cotransporter-2 inhibitor (sglt2i), dapagliflozin, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896641
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.